Aurora Funds

Aurora Funds is a venture capital firm that provides capital, connections, and strategic guidance to entrepreneurs with early-stage life sciences and information technology companies. Founded in 1994, Aurora manages over $234 million in five venture funds. The firm has managed investments in over 60 companies, resulting in five IPOs and eight M&A transactions to date. Aurora typically serves as a lead or co-lead investor in seed and early-stage financing opportunities located primarily in the Southeast and Mid-Atlantic regions of the United States. The firm's initial investment size ranges from $50,000 in a seed investment to as much as $2.5 million in a first-round financing. Aurora has the capacity to invest a total of between $4 million and $8 million across multiple rounds of financing as the company matures. The firm maintains a balanced investment focus across both life sciences and information technology industries.

Aurora Funds is headquartered in Cary, North Carolina, and has been actively investing in the Southeast United States since its inception. The firm's portfolio includes companies such as Argos Therapeutics and Regado Biosciences. Aurora's investment strategy emphasizes providing not only financial support but also strategic guidance and connections to help portfolio companies succeed in their respective markets. The firm's team comprises experienced professionals with backgrounds in both technology and life sciences, enabling them to effectively support a diverse range of startups. Aurora's commitment to the Southeast and Mid-Atlantic regions reflects its dedication to fostering innovation and economic growth within these areas.

Over the years, Aurora Funds has established a reputation for its hands-on approach to venture capital, working closely with entrepreneurs to navigate the challenges of scaling early-stage companies. The firm's track record of successful exits, including IPOs and M&A transactions, demonstrates its ability to identify and nurture high-potential startups. Aurora's focus on seed and early-stage investments allows it to play a pivotal role in the growth trajectories of emerging companies, providing them with the resources and expertise needed to achieve long-term success. The firm's balanced investment approach across life sciences and information technology sectors underscores its versatility and commitment to supporting innovation across multiple industries.